Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Chicken TIMP3 ELISA Kit (AC2620)
Cat.#: ASET-1209
Specifications
Description Chicken TIMP3 ELISA Kit allows for the in vitro quantitative determination of chicken TIMP3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Chicken Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.75 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.25-80 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1085 Sheep Leptin ELISA Kit (AC2496) Quantitative inquiry ASET-1017 Mouse Iba1 ELISA Kit (AC2428) Quantitative inquiry ASET-1342 Mouse Prokineticin Receptor 1 ELISA Kit (AC2753) Quantitative inquiry ASET-1706 Rat Visfatin ELISA Kit (AC3117) Quantitative inquiry ASET-2022 Human NOTCH3 ELISA Kit (AC3433) Quantitative inquiry ASET-1840 Human Neurexin 1 ELISA Kit (AC3251) Quantitative inquiry ASET-1876 Human TNF Receptor II ELISA Kit (AC3287) Quantitative inquiry ASET-1245 Human CYP1B1 ELISA Kit (AC2656) Quantitative inquiry ASET-1434 Rat Rabphilin 3A ELISA Kit (AC2845) Quantitative inquiry ASET-1906 Human LPPR4 ELISA Kit (AC3317) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket